Clinical trial access remains the biggest barrier in sarcoma care, with travel and insurance limits keeping patients from open studies, says Vicki Keedy, MD.
Vicki Keedy, MD
Advertisement
Articles by Vicki Keedy, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week
2
Clesrovimab Demonstrates Safety Through a Second RSV Season in High-Risk Infants
3
Dry Eye Disease Is More Than "Dry Eyes": Experts Explain the 2 Types
4
Multidisciplinary Teams Improve Biomarker Testing and Lung Cancer Care: Urs Weber, MD
5